Lakefront Biotherapeutics (LKFT) Other Non-Current Assets (2014 - 2026)

Lakefront Biotherapeutics (LKFT) has reported Other Non-Current Assets for 13 consecutive years, with $3.4 million the latest figure, recorded in Q1 2026.

• Quarterly Other Non-Current Assets rose 9.16% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 9.16% YoY) and the FY2025 annual result came in at $3.4 million, down 98.52% from the prior year.
• Other Non-Current Assets held at $3.4 million in Q1 2026 per LKFT's latest filing, from $3.4 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for LKFT reached as high as $5.3 billion in Q1 2022 and fell as low as $2.8 million in Q3 2025.
• A 5-year average of $2.4 billion and a median of $3.8 billion in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets soared 1145.69% — and 2025, when it tumbled 99.93%.
• Year by year, Other Non-Current Assets stood at $6.6 million in 2022, then soared by 178.12% to $18.3 million in 2023, then surged by 1145.69% to $227.8 million in 2024, then sank by 98.52% to $3.4 million in 2025, then fell by 0.17% to $3.4 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $3.4 million, $3.4 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.